CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Revenue, 2025
- $3.5M
- YoY, 2025
- −90.6%
- 5-year CAGR
- +37.3%
- 10-year CAGR
- +30.4%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $3.5M | −90.6% |
| 2024 | $37M | −89.9% |
| 2023 | $371M | +30,885.5% |
| 2022 | $1.2M | −99.9% |
| 2021 | $915M | +127,154.9% |
| 2020 | $719K | −99.8% |
| 2019 | $290M | +9,169.8% |
| 2018 | $3.1M | −92.4% |
| 2017 | $41M | +693.9% |
| 2016 | $5.2M | +1,990.7% |
| 2015 | $247K | — |